Oscar Health, Inc. (NYSE:OSCR) Receives Average Recommendation of “Hold” from Brokerages

Oscar Health, Inc. (NYSE:OSCR) has received a consensus rating of “Hold” from the nine brokerages that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $21.56.

Several brokerages have recently weighed in on OSCR. Piper Sandler restated an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. UBS Group began coverage on Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock. Jefferies Financial Group assumed coverage on Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price on the stock. Finally, Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th.

Oscar Health Trading Down 2.9 %

OSCR stock opened at $13.50 on Wednesday. The stock has a market cap of $3.34 billion, a price-to-earnings ratio of -225.00 and a beta of 1.63. The business’s 50-day moving average is $16.14 and its 200 day moving average is $17.51. Oscar Health has a 12-month low of $7.67 and a 12-month high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company’s revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.29) earnings per share. On average, sell-side analysts anticipate that Oscar Health will post -0.01 EPS for the current fiscal year.

Insider Activity

In other news, Vice Chairman Joshua Kushner bought 276,040 shares of the business’s stock in a transaction on Monday, November 11th. The shares were bought at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the transaction, the insider now directly owns 5,031,262 shares in the company, valued at $68,324,537.96. This trade represents a 5.80 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the completion of the sale, the chief accounting officer now directly owns 146,036 shares in the company, valued at approximately $2,640,330.88. The trade was a 5.24 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have bought 1,055,478 shares of company stock valued at $14,432,852 and have sold 103,610 shares valued at $1,847,519. Corporate insiders own 25.11% of the company’s stock.

Institutional Trading of Oscar Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. State Street Corp raised its position in Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after purchasing an additional 291,335 shares during the period. Geode Capital Management LLC grew its stake in shares of Oscar Health by 11.7% in the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock worth $92,062,000 after acquiring an additional 455,205 shares in the last quarter. Renaissance Technologies LLC grew its stake in shares of Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after acquiring an additional 934,600 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Oscar Health by 20.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company’s stock worth $33,940,000 after acquiring an additional 270,223 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of Oscar Health by 161.4% in the second quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock worth $22,038,000 after acquiring an additional 860,226 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.